Skip to main content
Clinical Trials/NCT00479245
NCT00479245TerminatedNot Applicable

WHODAS-II for Patients With Nonspecific Low Back Pain

Kovacs Foundation2 sites in 1 country200 target enrollmentStarted: April 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
200
Locations
2
Primary Endpoint
Measurement characteristics of WHODAS-II

Study Overview

Brief Summary

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule), as well as to analyze its correlation with low back pain (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ) and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients seen for nonspecific low back pain, with or without referred pain
  • Able to read and write
  • Have signed the informed consent form

Exclusion Criteria

  • Central nervous system pathology (with or without treatment)
  • Diagnosis of rheumatic inflammatory disease or fibromyalgia
  • Red flags for underlying systemic disease
  • Criteria for diagnosis of symptomatic herniated disc or symptomatic spinal stenosis

Outcomes

Primary Outcomes

Measurement characteristics of WHODAS-II

Time Frame: At baseline and at 7 days

Secondary Outcomes

  • Correlation between WHODAS-II and VAS, RMQ, FABQ and SF-12 in nonspecific low back pain(At baseline and at 7 days)

Investigators

Sponsor
Kovacs Foundation
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials